Inspire Medical Systems INSP recently showcased new clinical data, technology advancements and cardiovascular outcomes ...

The impact and effectiveness of clinical trial data sharing initiatives may differ depending on the data sharing model used. We characterized outcomes associated with models previously used by the U.S ...

The use of Artificial Intelligence (AI) and Machine Learning (ML) in clinical research is rapidly evolving, offering a glimpse into a future where medical innovation is driven by data-driven ...

In clinical trials, post-marketing approval studies remain a lower priority than other research areas, especially at community oncology centers.

NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced new experiences for enhancing and ...

Post-approval observational studies that rely on traditional data collection approaches may be burdensome for community oncology settings with limited research infrastructure. We conducted a ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Interim Findings from Prospective Randomized Controlled Trial of XWRAP® Support Continued Enrollment in Chronic Diabetic Foot Ulcer Study ...

Site augmentation emerges as a dynamic response to the growing complexity and volume of clinical trials, and the challenge of limited resources at clinical research sites. This support model, which is ...

This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.